Is There Any Real Difference Between Branded Drugs and Generic Substitutes?

A branded painkiller for ₹40 and a generic one for ₹4 sit next to each other on a chemist's shelf. The natural first thought — that if one costs ten times more it must be ten times better — is completely wrong. What the extra ₹36 is buying is a marketing budget and a supply chain that got the box to that shelf. It is not buying more medicine.

What is genuinely the same

Between a branded drug and a CDSCO-approved generic with the same active ingredient and strength:

• The molecule is identical.
• The amount per dose is identical.
• The clinical effect on the disease is identical in the vast majority of patients.
• The safety profile — side effects, drug interactions, contraindications — is identical.
• The absorption into the body is within a strict ±20-25% band (usually much tighter).

What can genuinely differ

• What: Fillers, binders, coatings · Impact: Usually none. Rare allergic reactions to a specific filler.
• What: Tablet appearance · Impact: Cosmetic only. Different shape or colour.
• What: Taste (chewables and syrups) · Impact: Can affect adherence in children — the taste of the branded version may be better tolerated
• What: Slow-release formulation · Impact: A branded 'SR' or 'XR' version is NOT interchangeable with a plain-release generic
• What: Combination products · Impact: A branded combination pill has a specific dose ratio — a generic may not match exactly

The one legitimate reason to prefer branded

Consistency. A patient stabilised on a specific brand of levothyroxine for their thyroid may have their TSH move noticeably if switched to another brand — not because the second brand is bad, but because the small absorption differences matter for a narrow-therapeutic-index drug. For these medicines, the argument for staying with the same brand is genuine. For the rest — which is most medicines — the argument dissolves.

What the price gap actually buys

The branded drug's price funds three things a generic manufacturer skipped:

• The original drug discovery and clinical trials — for the innovator only, and long since paid off for older molecules.
• Sales representatives visiting doctors.
• The marketing that makes the brand name memorable to patients.

None of the three make the tablet better. They make it more expensive.

A practical rule

For an acute course of a common medicine — an antibiotic, a painkiller, a decongestant — the generic is almost always the right choice. For a chronic medicine at a stable dose — thyroid, seizures, anticoagulation — decide with your doctor whether to stay on a specific brand. For everything else in between, ask specifically for the generic by salt name and check the price gap. Often it is not worth the argument; sometimes it saves a household several thousand rupees a year.

References

• NCBI PMC — Jan Aushadhi medicine affordability
• Applied Clinical Trials — regulating the generic drug process
• IMSDA — CDSCO on generic medicine quality